首页> 外文会议>World biomaterials congress >Development of bi-layer vascular constructs by combining polymer biomaterial and cellular self assembly
【24h】

Development of bi-layer vascular constructs by combining polymer biomaterial and cellular self assembly

机译:通过结合聚合物生物材料和细胞自组装来开发双层血管构造

获取原文

摘要

Introduction: Coronary Artery Disease (CAD) is one of the major causes of death and morbidity worldwide. This disease is caused by the clogging of coronary arteries due to calcium and fat deposits (known as plaques), that restrict the blood flow to the heart muscle. To overcome this problem, coronary artery by-pass grafting (CABG) surgery is performed. Though this surgical technique is widely used, it generally has drawbacks, such as unavailability of autologous grafts in case of multiple surgeries and immunogenic response with allogenic grafts. A potential alternative is to use synthetic grafts made of polymer materials as vascular substitutes. However, smaller diameter (<6mm) synthetic grafts often fail due to poor long term patency rates. A promising solution to this problem is the use of a novel methodology that combines biodegradable tubular polymeric scaffold along with cellular self-assembly for the synthesis of small diameter vascular conduits (Internal Diameter=5mm) that could be used as blood vessel substitutes. Materials and methods: The project involves the use of biodegradable Poly Lactic Acid (PLA) nanofiber tubular matrix generated by air spinning technique which works on the principle of using air pressure to obtain nanofibers from polymer solution. The polymer scaffolds are subjected to different surface treatments followed by vacuum drying and sterilization. Vascular Smooth Muscle Cells (VSMC) from low passage (thawed at passage £6) are seeded on these scaffolds in specialized cell seeding chambers and incubated with the cell culture medium. Meanwhile, using low passage fibroblast cells on tissue culture plates under incubation, cell sheets are generated, in 2 weeks. These fibroblast cell sheets are rolled around the VSMC seeded tubular scaffolds and incubated for 3-5 weeks to provide better resistance and to create tunica media and adventitia similar to a native blood vessel. All human cell based experiments were done with approval from Comite d'ethique de la recherche du CHU de Quebec. Results: Tubular PLA scaffolds up to a length of 8 cm were fabricated through air spinning. The thickness of these scaffolds is calculated to be around 400pm, using digital micrometer. The nanofiber morphology, porosity were characterized using Scanning Electron Microscopy (SEM) and the average pore size was found to be 5 μm. Immunofluorescence microscopy (IF) with Hoechst staining for nuclei reveals that VSMC infiltration of up to 300 μm is observed in PLA scaffold and the cell number is twice as high on surface gelatinization of PLA. The mean ultimate tensile stress value of the fibroblast cell sheet rolled VSMC seeded PLA scaffold is 0.539 MPa while its elastic modulus (EM) is 2.52 MPa which is less than EM value for conduits developed by self-assembly alone proving that our constructs have better elasticity properties. Discussion and conclusion: The novel method of combining our self-assembly technique with biomaterial scaffold for vascular substitute generation helps mimic the architecture of native blood vessel and creates better elastic properties while also minimizing the time involved.
机译:简介:冠状动脉疾病(CAD)是全球死亡和发病的主要原因之一。该疾病是由于钙和脂肪沉积物(称为斑块)引起的冠状动脉阻塞所致,从而限制了流向心肌的血流。为了克服这个问题,进行了冠状动脉旁路移植术(CABG)。尽管这种外科手术技术被广泛使用,但它通常具有一些缺点,例如在多次手术的情况下无法使用自体移植物,以及同种异体移植物的免疫原性反应。一种潜在的替代方法是使用由聚合物材料制成的合成移植物作为血管替代物。然而,由于长期通畅率低,较小直径(<6mm)的合成移植物通常会失败。解决该问题的一种有前途的解决方案是使用一种可生物降解的管状聚合物支架与细胞自组装相结合的新颖方法,用于合成可用作血管替代物的小直径血管导管(内径= 5mm)。材料和方法:该项目涉及使用通过空气纺丝技术产生的可生物降解的聚乳酸(PLA)纳米纤维管状基质,其原理是利用气压从聚合物溶液中获得纳米纤维。对该聚合物支架进行不同的表面处理,然后进行真空干燥和灭菌。将来自低传代的血管平滑肌细胞(VSMC)(在传代£6时解冻)接种在这些支架上的专用细胞接种室中,并与细胞培养基一起孵育。同时,在培养下在组织培养板上使用低传代成纤维细胞,在2周内产生细胞片。将这些成纤维细胞片在VSMC接种的管状支架周围滚动,孵育3-5周,以提供更好的抵抗力,并产生类似于天然血管的中膜和外膜。所有基于人体细胞的实验均在魁北克省城市伦理委员会的批准下完成。结果:通过空气纺丝制造了长度达8 cm的管状PLA支架。使用数字千分尺计算得出这些支架的厚度约为400pm。使用扫描电子显微镜(SEM)表征纳米纤维的形态,孔隙率,发现平均孔径为5μm。用Hoechst染色对细胞核进行的免疫荧光显微镜检查(IF)显示,在PLA支架中观察到的VSMC浸润高达300μm,并且细胞数量是PLA表面糊化的两倍。成纤维细胞薄板卷制的VSMC接种PLA支架的平均极限拉伸应力值为0.539 MPa,而其弹性模量(EM)为2.52 MPa,这比仅通过自组装开发的导管的EM值要低,这证明我们的结构具有更好的弹性特性。讨论与结论:将我们的自组装技术与生物材料支架相结合以产生血管代用品的新颖方法,有助于模仿天然血管的结构,创造更好的弹性,同时还可以最大程度地减少所需的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号